Deep-tech innovation
partner for founders,
executives, and boards.
Helping research-led teams make high-stakes technology, product, and capital decisions — from breakthrough science to commercial impact.
Start a conversation →
Deep-tech innovation
partner for founders,
executives, and boards.
Helping research-led teams make high-stakes technology, product, and capital decisions — from breakthrough science to commercial impact.
Start a conversation →What We Help Build
Strategy & Board-Level Judgment
Advising boards and executive teams on technically complex decisions with long-term capital, governance, and execution implications.
Product, Technology & Execution Pathways
Translating breakthrough science into executable product and manufacturing pathways, grounded in real-world scale-up constraints.
Capital, Governance & Scale
Preparing deep-tech ventures to withstand institutional scrutiny — across capital readiness, governance, and operational scale.
What We Help Build
Strategy & Board-Level Judgment
Advising boards and executive teams on technically complex decisions with long-term capital, governance, and execution implications.
Product, Technology & Execution Pathways
Translating breakthrough science into executable product and manufacturing pathways, grounded in real-world scale-up constraints.
Capital, Governance & Scale
Preparing deep-tech ventures to withstand institutional scrutiny — across capital readiness, governance, and operational scale.
Perspective Built From Repeated Execution
This perspective is shaped by repeated experience building and scaling deep-tech ventures — not advising from the sidelines.
From leading product development through clinical trials, designing advanced manufacturing facilities, and sitting in boardrooms where technical risk meets capital decisions.
Perspective Built From Repeated Execution
This perspective is shaped by repeated experience building and scaling deep-tech ventures — not advising from the sidelines.
From leading product development through clinical trials, designing advanced manufacturing facilities, and sitting in boardrooms where technical risk meets capital decisions.
About BadFish
BadFish is an independent, senior founder-led deep-tech advisory firm. We work with founders, executives, boards, VCs and investors on technically complex, capital-intensive decisions across semiconductors, photonics, quantum hardware, medical devices, and advanced manufacturing.
The firm combines deep technical understanding with practical experience in product development, advanced manufacturing, and commercialisation — shaping decisions where execution risk is high and irreversible choices carry long-term consequences.
All engagements are senior-led and hands-on.
About BadFish
BadFish is an independent, senior founder-led deep-tech advisory firm. We work with founders, executives, boards, VCs and investors on technically complex, capital-intensive decisions across semiconductors, photonics, quantum hardware, medical devices, and advanced manufacturing.
The firm combines deep technical understanding with practical experience in product development, advanced manufacturing, and commercialisation — shaping decisions where execution risk is high and irreversible choices carry long-term consequences.
All engagements are senior-led and hands-on.
Core Team
Core Team
Dr Anthony Brewer
Founder, BadFish Innovation · Managing Partner & LP, Silicon Catalyst Australia · Chair, Advisory Committee – Archer Materials (ASX: AXE)
Dr Anthony Brewer is a physicist, entrepreneur, and deep-tech innovation partner with experience translating advanced technologies into commercial products across semiconductors, quantum technologies, and HealthTech.
He founded BadFish to work with founders, boards, and research-led teams tackling technically demanding problems – helping them turn complex science into fundable strategy, defensible IP, and manufacturable products.
In parallel, Anthony serves as a Managing Partner and Limited Partner at Silicon Catalyst Australia and as Chair of the Advisory Committee at Archer Materials (ASX: AXE), providing board-level guidance to deep-tech companies operating under institutional and public-market scrutiny.
Previously, Anthony was Chief Technology Officer at WearOptimo, where he led AI-enabled wearable biosensor development from proof-of-concept through multi-year clinical trials and the design and build of an advanced manufacturing facility.
Anthony holds a PhD in semiconductor physics from the University of Cambridge and is an inventor on more than 40 patents.
Dr Anthony Brewer is a physicist, entrepreneur, and deep-tech innovation partner with experience translating advanced technologies into commercial products across semiconductors, quantum technologies, and HealthTech.
He founded BadFish to work with founders, boards, and research-led teams tackling technically demanding problems – helping them turn complex science into fundable strategy, defensible IP, and manufacturable products.
In parallel, Anthony serves as a Managing Partner and Limited Partner at Silicon Catalyst Australia and as Chair of the Advisory Committee at Archer Materials (ASX: AXE), providing board-level guidance to deep-tech companies operating under institutional and public-market scrutiny.
Previously, Anthony was Chief Technology Officer at WearOptimo, where he led AI-enabled wearable biosensor development from proof-of-concept through multi-year clinical trials and the design and build of an advanced manufacturing facility.
Anthony holds a PhD in semiconductor physics from the University of Cambridge and is an inventor on more than 40 patents.
Dr Beta Buzon
Senior Consultant
Dr Beta Buzon is a Senior Consultant at BadFish, providing delivery leadership across complex, multidisciplinary technology programs spanning medical devices, chemistry, biotechnology, and advanced manufacturing.
At BadFish, Beta leads high-impact projects from strategy through to coordinated execution in highly regulated, technically demanding environments. Her delivery work includes supporting the design development phase of an R&D and pilot manufacturing facility and coordinating clinical trial delivery.
Beta's research foundation is in chemistry and biosensing, with expertise in polymers, electrochemistry, and molecular recognition, including structure-switching aptamers and SELEX.
She also brings hands-on experience building the systems around the science – establishing laboratory operations, equipment procurement, safety systems, and team capability – supported by clear governance and technical reporting to executive and board stakeholders.
Beta holds a PhD in Chemistry from The University of Queensland.
Dr Beta Buzon is a Senior Consultant at BadFish, providing delivery leadership across complex, multidisciplinary technology programs spanning medical devices, chemistry, biotechnology, and advanced manufacturing.
At BadFish, Beta leads high-impact projects from strategy through to coordinated execution in highly regulated, technically demanding environments. Her delivery work includes supporting the design development phase of an R&D and pilot manufacturing facility and coordinating clinical trial delivery.
Beta's research foundation is in chemistry and biosensing, with expertise in polymers, electrochemistry, and molecular recognition, including structure-switching aptamers and SELEX.
She also brings hands-on experience building the systems around the science – establishing laboratory operations, equipment procurement, safety systems, and team capability – supported by clear governance and technical reporting to executive and board stakeholders.
Beta holds a PhD in Chemistry from The University of Queensland.
Selected Work
Experience across venture-backed, institutional, and publicly listed deep-tech organisations.
Selected Work
Experience across venture-backed, institutional, and publicly listed deep-tech organisations.
Semiconductors
Technology Strategy & Capital Readiness
Shaped technology strategy and investor narrative for a semiconductor venture, de-risking the path to a significant funding round.
Medical Devices
Product Development & Manufacturing Scale
Led technical development from proof-of-concept through manufacturing facility design for an AI-enabled wearable biosensor.
Quantum Hardware
Commercialisation Strategy
Shaped go-to-market strategy and partnership framework for a quantum computing hardware venture entering commercial scale.
Advanced Manufacturing
Facility Design & Operational Governance
Governed the design and construction of a state-of-the-art manufacturing facility for regulated medical devices.
Semiconductors
Technology Strategy & Capital Readiness
Shaped technology strategy and investor narrative for a semiconductor venture, de-risking the path to a significant funding round.
Medical Devices
Product Development & Manufacturing Scale
Led technical development from proof-of-concept through manufacturing facility design for an AI-enabled wearable biosensor.
Quantum Hardware
Commercialisation Strategy
Shaped go-to-market strategy and partnership framework for a quantum computing hardware venture entering commercial scale.
Advanced Manufacturing
Facility Design & Operational Governance
Governed the design and construction of a state-of-the-art manufacturing facility for regulated medical devices.
Board Advisory
Independent board-level advisory for deep-tech companies.
Supporting venture-backed companies, scaleups, and listed companies with technically-informed governance and strategic judgment.
Learn more →Board Advisory
Independent board-level advisory for deep-tech companies.
Supporting venture-backed companies, scaleups, and listed companies with technically-informed governance and strategic judgment.
Learn more →Let's talk.
If you're navigating a technically demanding path from science to commercial impact, we should talk.
Start a conversation →Let's talk.
If you're navigating a technically demanding path from science to commercial impact, we should talk.
Start a conversation →